Sangamo Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMO and other ETFs, options, and stocks.

About SGMO

Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. 

CEO
Alexander D. Macrae
CEOAlexander D. Macrae
Employees
183
Employees183
Headquarters
Richmond, California
HeadquartersRichmond, California
Founded
1995
Founded1995
Employees
183
Employees183

SGMO Key Statistics

Market cap
122.71M
Market cap122.71M
Price-Earnings ratio
-1.30
Price-Earnings ratio-1.30
Dividend yield
Dividend yield
Average volume
4.93M
Average volume4.93M
High today
$0.5079
High today$0.5079
Low today
$0.48
Low today$0.48
Open price
$0.50
Open price$0.50
Volume
918.89K
Volume918.89K
52 Week high
$3.18
52 Week high$3.18
52 Week low
$0.304
52 Week low$0.304

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%

People also own

Based on the portfolios of people who own SGMO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.